In conclusion, this study highlights the importance of TP53, NFκB, and GR signaling pathways in a clinical model of inflammation-related MDD and their potential as predictive biomarkers to identify individuals vulnerable to this type of depression. The gene discussed is NR3C1; the disease is major depressive disorder.